In contrast, a huge content of CD4, CD8, and CD19 lymphocytes and early mature and mature NK cells was found among the tumor-infiltrated immune cells after immunization of RtH-GD3P4 following the intensive scheme of administration, which correlates with the strong inhibition of the tumor growth (Figure 3B, right panel). The gene discussed is CD8A; the disease is neoplasm.